News
BrightHeart has gained a further 510(k) clearance from the FDA for its AI-based prenatal congenital heart defect (CHD) ...
Health Canada has approved Merit Medical Systems’ Wrapsody cell-impermeable endoprosthesis (CIE) device for haemodialysis ...
Roche has introduced the Elecsys PRO-C3 test for evaluating the liver fibrosis severity in individuals with signs of MASLD.
The Final Rule was mooted for implementation over a staged transition period, determined by a service’s risk level, by 2028.
URA has entered the consumer diabetes space, offering a new glucose feature for its ring that uses insights from Dexcom’s CGM ...
InBrain Neuroelectronics has won a €4m ($4.5m) grant from the Spanish Ministry of Industry and Tourism to develop its BCI ...
Tariffs, though designed as economic tools, have ripple effects that extend deeply into the regulatory framework of the ...
Zimmer Biomet has adjusted its 2025 earnings forecast to $7.90-$8.10 per share, down from previous estimates falling between ...
Firefly Neuroscience has completed the acquisition of Evoke Neuroscience, a developer of technologies aimed at assessing ...
Core has completed the acquisition of neurotechnology solution provider NeuroMetrix, including its Quell platform.
Endogenex has shared results from its REGENT-1 clinical study during the Digestive Disease Week (DDW) 2025 event held in San ...
Inquis Medical has reported that the trial of its Aventus thrombectomy system for pulmonary embolism (PE) met its primary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results